Heidi Gransar

Heidi Gransar

Auto-generated profile, based on publicly available information

Heidi Gransar

Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
MGMarkus Goeller
Markus Goeller
SAStephan Achenbach
Stephan Achenbach
MMMohamed Marwan
Mohamed Marwan
MDMhairi K. Doris
Mhairi K. Doris
SCSebastien Cadet
Sebastien Cadet
DDDamini Dey
Damini Dey

1 July 2018 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
JBJulian Betancur
Julian Betancur
YOYuka Otaki
Yuka Otaki
MMManish Motwani
Manish Motwani
MFMathews B. Fish
Mathews B. Fish
MLMark Lemley
Mark Lemley
PSPiotr J. Slomka
Piotr J. Slomka

1 December 2019 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
FCFrederic Commandeur
Frederic Commandeur
PSPiotr J Slomka
Piotr J Slomka
MGMarkus Goeller
Markus Goeller
XCXi Chen
Xi Chen
SCSebastien Cadet
Sebastien Cadet
DDDamini Dey
Damini Dey
Our aim was to evaluate the performance of machine learning (ML), integrating clinical parameters with coronary artery calcium (CAC), and automated epicardial adipose tissue (EAT) quantification, for the prediction of long-term risk of myocardial infarction (MI) and cardiac death in asymptomatic subjects. Our study included 1912 asymptomatic subjects [1117 (58.4%) male, age: 55.8 ± 9.1 years] from the prospective EISNER trial with long-term follow-up after CAC scoring. EAT volume and density were quantified using a fully automated deep learning method. ML extreme gradient boosting was trained using clinical co-variates, plasma lipid panel measurements, risk factors, CAC, aortic calcium, and automated EAT measures, and validated using repeated 10-fold cross validation. During mean follow-up of 14.5 ± 2 years, 76 events of MI and/or cardiac death occurred. ML obtained a significantly higher AUC than atherosclerotic cardiovascular disease (ASCVD) risk and CAC score for predicting events (ML: 0.82; ASCVD: 0.77; CAC: 0.77, P < 0.05 for all). Subjects with a higher ML score (by Youden’s index) had high hazard of suffering events (HR: 10.38, P < 0.001); the relationships persisted in multivariable analysis including ASCVD-risk and CAC measures (HR: 2.94, P = 0.005). Age, ASCVD-risk, and CAC were prognostically important for both genders. Systolic blood pressure was more important than cholesterol in women, and the opposite in men. In this prospective study, machine learning used to integrate clinical and quantitative imaging-based variables significantly improves prediction of MI and cardiac death compared with standard clinical risk assessment. Following further validation, such a personalized paradigm could potentially be used to improve cardiovascular risk assessment.

1 March 2016 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
MHMichaela M. Hell
Michaela M. Hell
XDXiaowei Ding
Xiaowei Ding
MRMathieu Rubeaux
Mathieu Rubeaux
PSPiotr Slomka
Piotr Slomka
HGHeidi Gransar
Heidi Gransar
DDDamini Dey
Damini Dey

1 February 2021 in Atherosclerosis
Verified
Journal Article
Closed access
BTBalaji K. Tamarappoo
Balaji K. Tamarappoo
ALAndrew Lin
Andrew Lin
FCFrederic Commandeur
Frederic Commandeur
PMPriscilla A. McElhinney
Priscilla A. McElhinney
SCSebastien Cadet
Sebastien Cadet
DDDamini Dey
Damini Dey

1 April 2020 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
CGCatherine Gebhard
Catherine Gebhard
MMMonika Maredziak
Monika Maredziak
MMMichael Messerli
Michael Messerli
RBRonny R Buechel
Ronny R Buechel
FLFay Lin
Fay Lin
PKPhilipp A Kaufmann
Philipp A Kaufmann
There are significant sex-specific differences in left ventricular ejection fraction (LVEF), with a higher LVEF being observed in women. We sought to assess the clinical relevance of an increased LVEF in women and men. A total of 4632 patients from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) registry (44.8% women; mean age 58.7 ± 13.2 years in men and 59.5 ± 13.3 years in women, P = 0.05), in whom LVEF was measured by cardiac computed tomography, were categorized according to LVEF (low 65%). The prevalence of high LVEF was similar in both sexes (33.5% in women and 32.5% in men, P = 0.46). After 6 years of follow-up, no difference in mortality was observed in patients with high LVEF in the overall cohort (P = 0.41). When data were stratified by sex, women with high LVEF died more often from any cause as compared to women with normal LVEF (8.6% vs. 7.1%, log rank P = 0.032), while an opposite trend was observed in men (5.8% vs. 6.8% in normal LVEF, log rank P = 0.89). Accordingly, a first order interaction term of male sex and high LVEF was significant (hazard ratios 0.63, 95% confidence intervals 0.41–0.98, P = 0.043) in a Cox regression model of all-cause mortality adjusted for age, cardiovascular risk factors, and severity of coronary artery disease (CAD). Increased LVEF is highly prevalent in patients referred for evaluation of CAD and is associated with an increased risk of death in women, but not in men. Differentiating between normal and hyperdynamic left ventricles might improve risk stratification in women with CAD. https://clinicaltrials.gov/ct2/show/NCT01443637.